Updates from FDA

At a recent meeting of CDC’s Advisory Committee of Immunization Practices (ACIP), the group recommended recombinant zoster vaccine (RZV) for adults 19 years and older who are immunodeficient or immunosuppressed as well as the routine use of select pneumococcal vaccines in adults 65 years and older and those aged 19 to 64 years with certain underlying medical conditions or other risk factors.

Maria G. Tanzi, PharmD

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in JAMA Internal Medicine.

Loren Bonner

A systematic review and meta-analysis by Yang and colleagues, published in JAMA Open Network in October 2021, found that 5-HT1F receptor agonists or “ditans” (lasmiditan) and calcitonin gene-related peptide antagonists or “gepants” (rimegepant and ubrogepant) were not as effective in reducing pain 2 hours post-dose as compared to triptans.

Clarissa Chan, PharmD

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults.

Loren Bonner